309 related articles for article (PubMed ID: 30101607)
21. Parsimony Principle and its Proper use/ Application in Computer-assisted Drug Design and QSAR.
Basak SC; Vracko MG
Curr Comput Aided Drug Des; 2020; 16(1):1-5. PubMed ID: 31934837
[No Abstract] [Full Text] [Related]
22. Ask the experts: computational chemistry.
Matta CF; Hutter MC
Future Med Chem; 2018 Jul; 10(13):1521-1524. PubMed ID: 29992825
[No Abstract] [Full Text] [Related]
23. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A
Nat Rev Drug Discov; 2024 Feb; 23(2):141-155. PubMed ID: 38066301
[TBL] [Abstract][Full Text] [Related]
24. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
[TBL] [Abstract][Full Text] [Related]
25. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
26. From computer-aided drug discovery to computer-driven drug discovery.
Frye L; Bhat S; Akinsanya K; Abel R
Drug Discov Today Technol; 2021 Dec; 39():111-117. PubMed ID: 34906321
[TBL] [Abstract][Full Text] [Related]
27. Peptide Therapeutics.
Vorherr T
Bioorg Med Chem; 2018 Jun; 26(10):2699. PubMed ID: 29778135
[No Abstract] [Full Text] [Related]
28. New Perspectives on Machine Learning in Drug Discovery.
Musella S; Verna G; Fasano A; Di Micco S
Curr Med Chem; 2021; 28(32):6704-6728. PubMed ID: 33176630
[TBL] [Abstract][Full Text] [Related]
29. CADD, AI and ML in drug discovery: A comprehensive review.
Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
[TBL] [Abstract][Full Text] [Related]
30. Artificial Intelligence and Cheminformatics-Guided Modern Privileged Scaffold Research.
Qiu HY; Clausen RP; He Y; Zhu HL
Curr Top Med Chem; 2021; 21(28):2593-2608. PubMed ID: 33982652
[TBL] [Abstract][Full Text] [Related]
31. Feature importance of machine learning prediction models shows structurally active part and important physicochemical features in drug design.
Sasahara K; Shibata M; Sasabe H; Suzuki T; Takeuchi K; Umehara K; Kashiyama E
Drug Metab Pharmacokinet; 2021 Aug; 39():100401. PubMed ID: 34089983
[TBL] [Abstract][Full Text] [Related]
32. Application of Computational Biology and Artificial Intelligence in Drug Design.
Zhang Y; Luo M; Wu P; Wu S; Lee TY; Bai C
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362355
[TBL] [Abstract][Full Text] [Related]
33. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
34. Artificial intelligence in pharmaceutical research and development.
Mitchell JB
Future Med Chem; 2018 Jul; 10(13):1529-1531. PubMed ID: 29966438
[No Abstract] [Full Text] [Related]
35. Accelerating antibiotic discovery through artificial intelligence.
Melo MCR; Maasch JRMA; de la Fuente-Nunez C
Commun Biol; 2021 Sep; 4(1):1050. PubMed ID: 34504303
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in fragment-based computational drug design: tackling simultaneous targets/biological effects.
Speck-Planche A
Future Med Chem; 2018 Sep; 10(17):2021-2024. PubMed ID: 30058835
[No Abstract] [Full Text] [Related]
37. Machine Learning in Drug Discovery and Development Part 1: A Primer.
Talevi A; Morales JF; Hather G; Podichetty JT; Kim S; Bloomingdale PC; Kim S; Burton J; Brown JD; Winterstein AG; Schmidt S; White JK; Conrado DJ
CPT Pharmacometrics Syst Pharmacol; 2020 Mar; 9(3):129-142. PubMed ID: 31905263
[TBL] [Abstract][Full Text] [Related]
38. Chemo-bioinformatics based mathematical descriptors and their applications in computational drug design.
Basak SC
Curr Comput Aided Drug Des; 2010 Dec; 6(4):223-4. PubMed ID: 20883196
[No Abstract] [Full Text] [Related]
39. A Structure-Based Drug Discovery Paradigm.
Batool M; Ahmad B; Choi S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174387
[TBL] [Abstract][Full Text] [Related]
40. On the contribution of molecular topology to drug design and discovery.
Gálvez J; García-Doménech R
Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
